StockWatch
·

TRANSPEK INDUSTRY LTD.-$

BSE: 506687

P/L Snapshot

Q1 FY27 · standalone

vs Q4 FY26·vs Q1 FY26
Revenue
155.06
+1.7%-6.5%
Expenditure
143.27
-0.3%-1.2%
Net Profit
8.93
+35.7%-42.7%
OPM %
13.33%
+1.37pp-2.26pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.0048.9897.96146.94195.92Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Price Chart
Reports

Profit halved, growth stalled—the capex bet is now the story

Arclin concentration · capex execution · product pipeline risk

Result verdictFollow-upQ1 FY2725 Aug 20266 minMetals & Mining

Stalled growth, halved profit; restructuring play with R&D upside

product diversification · margin pressure · capacity constraints

TranscriptDeep diveQ1 FY2725 Aug 20266 minMetals & Mining

Transpek Q1 FY27: consolidated PAT falls 43% YoY to ₹8.93 Cr on margin compression

specialty chemicals · margin compression · profit decline

ResultsQ1 FY2707 Aug 20263 minMetals & Mining
Latest

Corporate Events

Board MeetingTRANSPEK
2026
15Sep

Board Meeting

The Annual General Meeting of the Company is scheduled to be…

BSE Filing
Board MeetingTRANSPEK
2026
7Aug

Board Meeting

The meeting of the Board of Directors of the Company will be…

BSE Filing
Board MeetingTRANSPEK
2026
26May

Board Meeting

The board meeting is scheduled to consider and approve the A…

BSE Filing
Board MeetingTRANSPEK
2025
7May

Board Meeting

Consider and approve the Audited Standalone and Consolidated…

BSE Filing
Board MeetingTRANSPEK
2024
13Nov

Board Meeting

consider and approve The Unaudited Financial

BSE Filing
Board MeetingTRANSPEK
2024
21May

Board Meeting

Consider and approve Audited Financial Statements for the fo…

BSE Filing
Board MeetingTRANSPEK
2024
12Feb

Board Meeting

Consider and approve Unaudited Financial Results for the qua…

BSE Filing
Board MeetingTRANSPEK
2023
6Nov

Board Meeting

Consider and approve Unaudited Results for the quarter ended…

BSE Filing